Monday, March 18, 2013

PhRMA Cheers Progress in Biotech

Report cites more than 900 biologic therapies and vaccines in development.

The Burrill Report

American biopharmaceutical companies are using biotechnology to develop more than 900 medicines and vaccines targeting more than 100 diseases, according to a new catalog of therapeutic candidates published by the Pharmaceutical Research and Manufacturers of America.

“These medicines reflect the cuttin
g-edge research being conducted across the country by biopharmaceutical companies in order to provide new treatment options to patients,” says John Castellani, PhRMA’s president and CEO.

No comments:

Post a Comment